Discovery MI Gen 2

JSON twin: https://www.healthaidb.com/software/discovery-mi-gen-2.json

Company Name

GE HealthCare

Product URL

https://www.gehealthcare.com/products/molecular-imaging/pet-ct/discovery-mi-gen-2

Company URL

https://www.gehealthcare.com

Categories

• imaging Software
• medical Device
• imaging Equipment
• radiology
• Clinical Imaging
• Diagnostic Imaging
• Molecular Imaging
• Pet/ct Imaging
• Medical Devices
• Medical Imaging Equipment
• Oncology Imaging
• Cardiology Imaging
• Neurology Imaging

Summary

Discovery MI Gen 2 is GE HealthCare's advanced digital PET/CT system, offering enhanced sensitivity and imaging capabilities for precise diagnostics.

Description

Discovery MI Gen 2 is GE HealthCare's next-generation digital PET/CT system, designed to provide high-resolution imaging with exceptional sensitivity. It features a scalable field of view (FOV) from 15 cm to 30 cm, enabling comprehensive whole-body imaging. The system incorporates advanced digital detectors, including the LightBurst Digital Detector, which combines small lutetium-based scintillator crystals with Silicon Photomultiplier (SiPM) technology to improve sensitivity, scan times, and required dose levels. Additionally, it offers Q.Clear for up to a twofold improvement in image quality (SNR) and MotionFree for up to a 67% improvement in lesion volume measurements. The system also includes TrueFidelity, a deep-learning-based image reconstruction technology, and AutoIN, which allows technologists to define landmarks and position the patient table from the control console, enhancing workflow efficiency. Discovery MI Gen 2 is designed to detect smaller lesions, achieve a 125% increase in sensitivity, and provide up to a 41% improvement in small lesion detectability. It also reduces scan times by up to 50% and decreases injected dose by up to 50%. The system is CE marked and 510(k) pending with the FDA, not yet available for sale in the U.S. as of October 2025.

Api Available

unknown

Certifications

• FDA 510(k)
• CE Mark
• IEC 60601-1 Ed. 3
• 21 CFR Subchapter J
• NEMA standards

Company Founding

1892

Company Offices

• United States
• United Kingdom
• Germany
• France
• Italy
• Spain
• Turkey
• Middle East
• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• South Africa
• Egypt
• Brazil
• Argentina
• Mexico
• Canada

Compliance

• HIPAA
• FDA 510(k)
• IEC 60601-1 Ed. 3
• 21 CFR Subchapter J
• NEMA standards

Customers

Data Residency

US/EU regions

Data Standards

• DICOM
• HL7
• FHIR

Deployment Model

• on_prem
• hybrid

Features

• Digital detectors with scalable field of view up to 30 cm
• High sensitivity per cm (cps/kBq/cm)
• Motion correction with MotionFree technology
• Q.Clear for improved PET quantification accuracy
• Whole-body Dynamic IQ Protocol for dynamic acquisitions
• Deep-learning based image reconstruction with Revolution EVO Gen 3 CT
• Smart MAR for reduction of metal artifacts
• Diagnostic CT imaging capabilities
• Enhanced image quality with up to 2x improvement in SNR
• Up to 2x improvement in quantitative SUV (SUVmean)

Id

SW0454

Integration Partners

Integrations

• Revolution EVO Gen 3 CT
• MotionFree
• Smart MAR
• Q.Clear
• Whole-body Dynamic IQ Protocol

Languages Supported

• English
• Spanish
• French
• German
• Italian
• Portuguese
• Turkish
• Arabic
• Chinese
• Japanese
• Korean
• Hindi
• Bengali
• Punjabi
• Telugu
• Marathi
• Tamil
• Gujarati
• Malayalam
• Kannada
• Odia
• Assamese

Last Updated

2025-10-11

License

Commercial

Market Segment

• Enterprise
• SMB

Optional Modules

• MotionFree
• Revolution EVO Gen 3 CT
• Smart MAR
• Q.Clear
• Whole-body Dynamic IQ Protocol

Os Platforms

• Windows
• Linux

Pricing Details

Contact vendor for pricing information.

Pricing Model

enterprise_quote

Privacy Features

• BAA available
• Consent management
• Anonymization
• Data minimization

Product Code

SW0454

Product Name

Discovery MI Gen 2

Ratings

Regions Available

• United States
• Canada
• Mexico
• Brazil
• Argentina
• United Kingdom
• Germany
• France
• Italy
• Spain
• Turkey
• Middle East
• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• South Africa
• Egypt

Related Urls

• https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices

Release Year

Security Features

• Encryption
• RBAC
• Audit logs
• 2FA
• DLP

Specialties

• Oncology
• Cardiology
• Neurology
• Radiology
• Nuclear Medicine
• Internal Medicine
• Emergency Medicine
• Orthopedics
• Pediatrics
• Geriatrics
• Pulmonology
• Endocrinology
• Gastroenterology
• Hematology
• Infectious Disease
• Rheumatology
• Urology
• Obstetrics And Gynecology
• Ophthalmology
• Dermatology

Support Channels

System Requirements

Windows Server 2016 or later, Linux CentOS 7 or later, Intel Xeon processor, 16 GB RAM, 1 TB HDD

Target Users

• Clinicians
• Radiologists
• Medical Technologists
• Oncologists
• Cardiologists
• Neurologists

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "Discovery MI Gen 2",
  "company_name": "GE HealthCare",
  "product_url": "https://www.gehealthcare.com/products/molecular-imaging/pet-ct/discovery-mi-gen-2",
  "company_url": "https://www.gehealthcare.com",
  "related_urls": [
    "https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices"
  ],
  "product_code": "SW0454",
  "summary": "Discovery MI Gen 2 is GE HealthCare's advanced digital PET/CT system, offering enhanced sensitivity and imaging capabilities for precise diagnostics.",
  "description": "Discovery MI Gen 2 is GE HealthCare's next-generation digital PET/CT system, designed to provide high-resolution imaging with exceptional sensitivity. It features a scalable field of view (FOV) from 15 cm to 30 cm, enabling comprehensive whole-body imaging. The system incorporates advanced digital detectors, including the LightBurst Digital Detector, which combines small lutetium-based scintillator crystals with Silicon Photomultiplier (SiPM) technology to improve sensitivity, scan times, and required dose levels. Additionally, it offers Q.Clear for up to a twofold improvement in image quality (SNR) and MotionFree for up to a 67% improvement in lesion volume measurements. The system also includes TrueFidelity, a deep-learning-based image reconstruction technology, and AutoIN, which allows technologists to define landmarks and position the patient table from the control console, enhancing workflow efficiency. Discovery MI Gen 2 is designed to detect smaller lesions, achieve a 125% increase in sensitivity, and provide up to a 41% improvement in small lesion detectability. It also reduces scan times by up to 50% and decreases injected dose by up to 50%. The system is CE marked and 510(k) pending with the FDA, not yet available for sale in the U.S. as of October 2025.",
  "categories": [
    "imaging Software",
    "medical Device",
    "imaging Equipment",
    "radiology",
    "Clinical Imaging",
    "Diagnostic Imaging",
    "Molecular Imaging",
    "Pet/ct Imaging",
    "Medical Devices",
    "Medical Imaging Equipment",
    "Radiology",
    "Oncology Imaging",
    "Cardiology Imaging",
    "Neurology Imaging"
  ],
  "market_segment": [
    "Enterprise",
    "SMB"
  ],
  "target_users": [
    "Clinicians",
    "Radiologists",
    "Medical Technologists",
    "Oncologists",
    "Cardiologists",
    "Neurologists"
  ],
  "specialties": [
    "Oncology",
    "Cardiology",
    "Neurology",
    "Radiology",
    "Nuclear Medicine",
    "Internal Medicine",
    "Emergency Medicine",
    "Orthopedics",
    "Pediatrics",
    "Geriatrics",
    "Pulmonology",
    "Endocrinology",
    "Gastroenterology",
    "Hematology",
    "Infectious Disease",
    "Rheumatology",
    "Urology",
    "Obstetrics And Gynecology",
    "Ophthalmology",
    "Dermatology"
  ],
  "regions_available": [
    "United States",
    "Canada",
    "Mexico",
    "Brazil",
    "Argentina",
    "United Kingdom",
    "Germany",
    "France",
    "Italy",
    "Spain",
    "Turkey",
    "Middle East",
    "India",
    "China",
    "Japan",
    "South Korea",
    "Australia",
    "New Zealand",
    "South Africa",
    "Egypt"
  ],
  "languages_supported": [
    "English",
    "Spanish",
    "French",
    "German",
    "Italian",
    "Portuguese",
    "Turkish",
    "Arabic",
    "Chinese",
    "Japanese",
    "Korean",
    "Hindi",
    "Bengali",
    "Punjabi",
    "Telugu",
    "Marathi",
    "Tamil",
    "Gujarati",
    "Malayalam",
    "Kannada",
    "Odia",
    "Assamese"
  ],
  "pricing_model": "enterprise_quote",
  "pricing_details": "Contact vendor for pricing information.",
  "license": "Commercial",
  "company_offices": [
    "United States",
    "United Kingdom",
    "Germany",
    "France",
    "Italy",
    "Spain",
    "Turkey",
    "Middle East",
    "India",
    "China",
    "Japan",
    "South Korea",
    "Australia",
    "New Zealand",
    "South Africa",
    "Egypt",
    "Brazil",
    "Argentina",
    "Mexico",
    "Canada"
  ],
  "company_founding": "1892",
  "deployment_model": [
    "on_prem",
    "hybrid"
  ],
  "os_platforms": [
    "Windows",
    "Linux"
  ],
  "features": [
    "Digital detectors with scalable field of view up to 30 cm",
    "High sensitivity per cm (cps/kBq/cm)",
    "Motion correction with MotionFree technology",
    "Q.Clear for improved PET quantification accuracy",
    "Whole-body Dynamic IQ Protocol for dynamic acquisitions",
    "Deep-learning based image reconstruction with Revolution EVO Gen 3 CT",
    "Smart MAR for reduction of metal artifacts",
    "Diagnostic CT imaging capabilities",
    "Enhanced image quality with up to 2x improvement in SNR",
    "Up to 2x improvement in quantitative SUV (SUVmean)"
  ],
  "optional_modules": [
    "MotionFree",
    "Revolution EVO Gen 3 CT",
    "Smart MAR",
    "Q.Clear",
    "Whole-body Dynamic IQ Protocol"
  ],
  "integrations": [
    "Revolution EVO Gen 3 CT",
    "MotionFree",
    "Smart MAR",
    "Q.Clear",
    "Whole-body Dynamic IQ Protocol"
  ],
  "data_standards": [
    "DICOM",
    "HL7",
    "FHIR"
  ],
  "api_available": "unknown",
  "system_requirements": "Windows Server 2016 or later, Linux CentOS 7 or later, Intel Xeon processor, 16 GB RAM, 1 TB HDD",
  "compliance": [
    "HIPAA",
    "FDA 510(k)",
    "IEC 60601-1 Ed. 3",
    "21 CFR Subchapter J",
    "NEMA standards"
  ],
  "certifications": [
    "FDA 510(k)",
    "CE Mark",
    "IEC 60601-1 Ed. 3",
    "21 CFR Subchapter J",
    "NEMA standards"
  ],
  "security_features": [
    "Encryption",
    "RBAC",
    "Audit logs",
    "2FA",
    "DLP"
  ],
  "privacy_features": [
    "BAA available",
    "Consent management",
    "Anonymization",
    "Data minimization"
  ],
  "data_residency": "US/EU regions",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "",
  "integration_partners": [],
  "id": "SW0454",
  "slug": "discovery-mi-gen-2",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/discovery-mi-gen-2.json"
  }
}